MIGUEL ARCE: Open Payments
NPI 1487736096 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 28 payments from 9 companies in 2025. Trend: 2023 $1,102 · 2024 $712 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $160 |
| Lundbeck LLC | 4 | $113 |
| E.R. Squibb & Sons, L.L.C. | 5 | $99 |
| Alkermes, Inc. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Luye Pharma (USA) Ltd. | 1 | $32 |
| ABBVIE INC. | 1 | $20 |
Products named: ABILIFY ASIMTUFII, COBENFY, HETLIOZ, ABILIFY MAINTENA, ARISTADA, UZEDY, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
